MILANO VINCENT has filed 28 insider transactions across 2 companies since February 2023.
Most recent transaction: a grant/award of 848 shares of BIOCRYST PHARMACEUTICALS INC ($BCRX) on February 27, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Common Stock | 848 | $8.75 | 92,067.0000 | 219,885,000 | 0.93% | 0.00% |
| Nov. 28, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Common Stock | 783 | $7.18 | 91,219.0000 | 219,885,000 | 0.87% | 0.00% |
| Aug. 29, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Common Stock | 676 | $8.31 | 90,436.0000 | 206,696,000 | 0.75% | 0.00% |
| June 12, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Common Stock | 12500 | $0.00 | 89,760.0000 | 206,696,000 | 16.18% | 0.01% |
| June 12, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Automatic Stock Option Grant | 27181 | $0.00 | 27,181.0000 | 206,696,000 | 9999.99% | 0.01% |
| June 6, 2025 | Aclaris Therapeutics, Inc. | $ACRS | MILANO VINCENT | Not found | M | Restricted Stock Units | 4793 | $0.00 | 0.0000 | 122,390,303 | 100.00% | 0.00% |
| June 6, 2025 | Aclaris Therapeutics, Inc. | $ACRS | MILANO VINCENT | Not found | M | Common Stock | 4793 | $0.00 | 17,316.0000 | 122,390,303 | 38.27% | 0.00% |
| June 5, 2025 | Aclaris Therapeutics, Inc. | $ACRS | MILANO VINCENT | Not found | A | Restricted Stock Units | 11580 | $0.00 | 11,580.0000 | 122,390,303 | 9999.99% | 0.01% |
| June 5, 2025 | Aclaris Therapeutics, Inc. | $ACRS | MILANO VINCENT | Not found | A | Stock Option (Right to Buy) | 42350 | $0.00 | 42,350.0000 | 122,390,303 | 9999.99% | 0.03% |
| May 30, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Common Stock | 523 | $10.75 | 77,260.0000 | 206,696,000 | 0.68% | 0.00% |
| Feb. 28, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Common Stock | 653 | $8.61 | 76,737.0000 | 206,696,000 | 0.86% | 0.00% |
| Nov. 29, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Common Stock | 750 | $7.50 | 76,084.0000 | 206,905,000 | 1.00% | 0.00% |
| Aug. 30, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Common Stock | 647 | $8.69 | 75,334.0000 | 192,198,000 | 0.87% | 0.00% |
| June 12, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Automatic Stock Option Grant | 49933 | $0.00 | 49,933.0000 | 192,198,000 | 9999.99% | 0.03% |
| June 12, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Common Stock | 6820 | $0.00 | 74,687.0000 | 192,198,000 | 10.05% | 0.00% |
| June 6, 2024 | Aclaris Therapeutics, Inc. | $ACRS | MILANO VINCENT | Not found | A | Restricted Stock Units | 4793 | $0.00 | 4,793.0000 | 71,074,858 | 9999.99% | 0.01% |
| June 6, 2024 | Aclaris Therapeutics, Inc. | $ACRS | MILANO VINCENT | Not found | A | Stock Option (Right to Buy) | 15750 | $0.00 | 15,750.0000 | 71,074,858 | 9999.99% | 0.02% |
| June 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | MILANO VINCENT | Not found | M | Common Stock | 4660 | $0.00 | 12,523.0000 | 71,074,858 | 59.26% | 0.01% |
| June 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | MILANO VINCENT | Not found | M | Restricted Stock Units | 4660 | $0.00 | 0.0000 | 71,074,858 | 100.00% | 0.01% |
| May 31, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Common Stock | 870 | $6.46 | 67,867.0000 | 192,198,000 | 1.30% | 0.00% |
| May 20, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | P | Common Stock | 15000 | $6.25 | 66,997.0000 | 192,198,000 | 28.85% | 0.01% |
| Feb. 29, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Common Stock | 999 | $5.63 | 51,997.0000 | 192,198,000 | 1.96% | 0.00% |
| Nov. 30, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Common Stock | 956 | $5.88 | 50,998.0000 | 185,908,000 | 1.91% | 0.00% |
| Aug. 31, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Common Stock | 791 | $7.11 | 50,042.0000 | 185,908,000 | 1.61% | 0.00% |
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Common Stock | 16745 | $0.00 | 49,251.0000 | 185,908,000 | 51.51% | 0.01% |
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Automatic Stock Option Grant | 39072 | $0.00 | 39,072.0000 | 185,908,000 | 9999.99% | 0.02% |
| May 31, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Common Stock | 680 | $8.27 | 32,506.0000 | 185,908,000 | 2.14% | 0.00% |
| Feb. 28, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | MILANO VINCENT | Director | A | Common Stock | 635 | $8.85 | 31,826.0000 | 185,908,000 | 2.04% | 0.00% |